Cargando…
EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE
Autores principales: | Shiga, Hisashi, Moroi, Rintaro, Makuuchi, Motoki, Takahashi, Takahiro, Shimoyama, Yusuke, Kuroha, Masatake, Kakuta, Yoichi, Kinouchi, Yoshitaka, Masamune, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212507/ http://dx.doi.org/10.1016/S0016-5085(22)62599-X |
Ejemplares similares
-
Long‐term effectiveness of ustekinumab comparable to antitumor necrosis factor agents in patients with Crohn's disease
por: Shiga, Hisashi, et al.
Publicado: (2022) -
Endoscopic radial incision and cutting for Crohn’s Disease-associated intestinal stricture: a pilot study
por: Moroi, Rintaro, et al.
Publicado: (2020) -
A pilot study investigating the safety and feasibility of endoscopic dilation using a radial incision and cutting technique for benign strictures of the small intestine: a study protocol
por: Moroi, Rintaro, et al.
Publicado: (2022) -
TL1A (TNFSF15) genotype affects the long‐term therapeutic outcomes of anti‐TNFα antibodies for Crohn's disease patients
por: Endo, Katsuya, et al.
Publicado: (2020) -
Serum C-reactive protein and albumin are useful biomarkers for tight control management of Crohn’s disease in Japan
por: Shiga, Hisashi, et al.
Publicado: (2020)